The heart in Grave's disease (overactive thyroid): Difference between revisions

Jump to navigation Jump to search
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +))
 
m (Robot: Automated text replacement (-{{reflist}} +{{reflist|2}}, -<references /> +{{reflist|2}}, -{{WikiDoc Cardiology Network Infobox}} +))
 
Line 1: Line 1:
{{SI}}
{{SI}}
{{WikiDoc Cardiology Network Infobox}}
 
{{WikiDoc Cardiology News}}
{{WikiDoc Cardiology News}}
{{CMG}}  
{{CMG}}  

Latest revision as of 15:30, 6 September 2012

WikiDoc Resources for The heart in Grave's disease (overactive thyroid)

Articles

Most recent articles on The heart in Grave's disease (overactive thyroid)

Most cited articles on The heart in Grave's disease (overactive thyroid)

Review articles on The heart in Grave's disease (overactive thyroid)

Articles on The heart in Grave's disease (overactive thyroid) in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on The heart in Grave's disease (overactive thyroid)

Images of The heart in Grave's disease (overactive thyroid)

Photos of The heart in Grave's disease (overactive thyroid)

Podcasts & MP3s on The heart in Grave's disease (overactive thyroid)

Videos on The heart in Grave's disease (overactive thyroid)

Evidence Based Medicine

Cochrane Collaboration on The heart in Grave's disease (overactive thyroid)

Bandolier on The heart in Grave's disease (overactive thyroid)

TRIP on The heart in Grave's disease (overactive thyroid)

Clinical Trials

Ongoing Trials on The heart in Grave's disease (overactive thyroid) at Clinical Trials.gov

Trial results on The heart in Grave's disease (overactive thyroid)

Clinical Trials on The heart in Grave's disease (overactive thyroid) at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on The heart in Grave's disease (overactive thyroid)

NICE Guidance on The heart in Grave's disease (overactive thyroid)

NHS PRODIGY Guidance

FDA on The heart in Grave's disease (overactive thyroid)

CDC on The heart in Grave's disease (overactive thyroid)

Books

Books on The heart in Grave's disease (overactive thyroid)

News

The heart in Grave's disease (overactive thyroid) in the news

Be alerted to news on The heart in Grave's disease (overactive thyroid)

News trends on The heart in Grave's disease (overactive thyroid)

Commentary

Blogs on The heart in Grave's disease (overactive thyroid)

Definitions

Definitions of The heart in Grave's disease (overactive thyroid)

Patient Resources / Community

Patient resources on The heart in Grave's disease (overactive thyroid)

Discussion groups on The heart in Grave's disease (overactive thyroid)

Patient Handouts on The heart in Grave's disease (overactive thyroid)

Directions to Hospitals Treating The heart in Grave's disease (overactive thyroid)

Risk calculators and risk factors for The heart in Grave's disease (overactive thyroid)

Healthcare Provider Resources

Symptoms of The heart in Grave's disease (overactive thyroid)

Causes & Risk Factors for The heart in Grave's disease (overactive thyroid)

Diagnostic studies for The heart in Grave's disease (overactive thyroid)

Treatment of The heart in Grave's disease (overactive thyroid)

Continuing Medical Education (CME)

CME Programs on The heart in Grave's disease (overactive thyroid)

International

The heart in Grave's disease (overactive thyroid) en Espanol

The heart in Grave's disease (overactive thyroid) en Francais

Business

The heart in Grave's disease (overactive thyroid) in the Marketplace

Patents on The heart in Grave's disease (overactive thyroid)

Experimental / Informatics

List of terms related to The heart in Grave's disease (overactive thyroid)

Template:WikiDoc Cardiology News Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor: Cafer Zorkun, M.D., Ph.D. [2]



Overview

Grave’s disease is the most frequent reason (approximately 60-90%) of thyrotoxicosis that results from thyroid hormone excess and 10 times more frequently occurs in women than in men.

Symptoms

1. Palpitations due to;

  • Sinus tachycardia (at rest, at sleep sleep, and during exercise) is the most frequently observed rhythm disturbances.

2. Exercise intolerance

3. Dyspnea on exertion

4. Chest pain

5. Pretibial edema

6. Dilated cardiomyopathy: Cardiomyopathy may be reversible [1] or resistant [2] to treatment.

7. Congestive heart failure (especially in elderly patients)

Diagnosis

Electrocardiography

Echocardiography

Treatment

Patients with atrial fibrillation should monitored and properly anticoagulated to prevent embolic complications and stroke.

Prognosis

References


Template:WikiDoc Sources

  1. Bauerlein EJ, Chakko CS, Kessler KM. Reversible dilated cardiomyopathy due to thyrotoxicosis. Am J Cardiol 1992; 70: 132
  2. Ebisawa K, Ikeda U, Murata M, et al. Irreversible cardiomyopathy due to thyrotoxicosis Cardiology 1994; 84: 274-277